Life Science CIOs, Accelerate Clinical Development With New Applications of Artificial Intelligence

As artificial intelligence continues to expand in all industries, clinical development and the life sciences are adopting a variety of AI software to simplify their workflows and organization challenges.  Gartner recently published a research naming Aspen Insights as a Representative Vendor for clinical development subject curation and protocol optimization Use Case.

“The idea that AI will be embedded in every software application and used to augment existing capabilities begins to reach mainstream acceptance, and solution vendors are under more pressure to shoehorn AI into their solutions and make them “smarter.” For life science (LS) CIOs who wish to optimize clinical trials, this is an appealing trend as sourcing teams can focus on selecting solution vendors who have prebuilt AI capabilities and expertise, rather than build from scratch. Even so, there remains experimental situations, notably in drug discovery research, where homegrown capabilities will need to be built with internal resources or with an AI-savvy technology partner.”

Download the research/report to read more about how CIOs can demystify AI and identify the right approaches to ensure successful AI initiatives.

Get The Report

    Gartner,Life Science CIOs, Accelerate Clinical Development With New Applications of Artificial Intelligence,Jeff Smith,31 October 2022
    GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
    Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.